

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.94124701 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.56872942 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19684820 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.15551119 |
| 5 | sodium ion export (GO:0071436) | 4.65444585 |
| 6 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.61303303 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.58688412 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.47539068 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 4.34379038 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 4.31770197 |
| 11 | glutamate secretion (GO:0014047) | 4.31119403 |
| 12 | vocalization behavior (GO:0071625) | 4.28534478 |
| 13 | cell communication by electrical coupling (GO:0010644) | 4.21155374 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.20285893 |
| 15 | regulation of histone H3-K27 methylation (GO:0061085) | 4.18785189 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.09108056 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 4.03280883 |
| 18 | activation of protein kinase A activity (GO:0034199) | 3.99212896 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.89919559 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.87950332 |
| 21 | exploration behavior (GO:0035640) | 3.85050693 |
| 22 | neurotransmitter secretion (GO:0007269) | 3.83457493 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.74291306 |
| 24 | dendritic spine morphogenesis (GO:0060997) | 3.71513537 |
| 25 | proline transport (GO:0015824) | 3.67101403 |
| 26 | potassium ion import (GO:0010107) | 3.58208816 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.56707101 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.54390583 |
| 29 | vitamin transmembrane transport (GO:0035461) | 3.53198359 |
| 30 | glycine transport (GO:0015816) | 3.52685507 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50245829 |
| 32 | cell communication involved in cardiac conduction (GO:0086065) | 3.46626557 |
| 33 | regulation of ARF protein signal transduction (GO:0032012) | 3.40905259 |
| 34 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.39853462 |
| 35 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.36261211 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.34075203 |
| 37 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.33943249 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30904841 |
| 39 | neuromuscular process controlling balance (GO:0050885) | 3.28149819 |
| 40 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.26475780 |
| 41 | regulation of RNA export from nucleus (GO:0046831) | 3.25688381 |
| 42 | adherens junction assembly (GO:0034333) | 3.25031973 |
| 43 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.23550386 |
| 44 | cellular sodium ion homeostasis (GO:0006883) | 3.22251685 |
| 45 | membrane repolarization (GO:0086009) | 3.22136947 |
| 46 | desmosome organization (GO:0002934) | 3.18472214 |
| 47 | neuronal action potential propagation (GO:0019227) | 3.14568035 |
| 48 | long-term memory (GO:0007616) | 3.14230317 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 3.11853740 |
| 50 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.09791734 |
| 51 | focal adhesion assembly (GO:0048041) | 3.07512916 |
| 52 | cell-substrate adherens junction assembly (GO:0007045) | 3.07512916 |
| 53 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.07028651 |
| 54 | protein localization to synapse (GO:0035418) | 3.05280057 |
| 55 | NADH metabolic process (GO:0006734) | 3.05136463 |
| 56 | membrane repolarization during action potential (GO:0086011) | 3.03354580 |
| 57 | response to pheromone (GO:0019236) | 3.03066308 |
| 58 | potassium ion homeostasis (GO:0055075) | 3.02805132 |
| 59 | COPI coating of Golgi vesicle (GO:0048205) | 3.00613475 |
| 60 | Golgi transport vesicle coating (GO:0048200) | 3.00613475 |
| 61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.00086259 |
| 62 | dendrite morphogenesis (GO:0048813) | 2.96121208 |
| 63 | regulation of membrane repolarization (GO:0060306) | 2.95007957 |
| 64 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.94427685 |
| 65 | neurotransmitter transport (GO:0006836) | 2.94078360 |
| 66 | positive regulation of membrane potential (GO:0045838) | 2.93816694 |
| 67 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.93780687 |
| 68 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.93482909 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 2.92340817 |
| 70 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.91871695 |
| 71 | alanine transport (GO:0032328) | 2.91707969 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.88794629 |
| 73 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.88136690 |
| 74 | cell volume homeostasis (GO:0006884) | 2.87107845 |
| 75 | establishment of nucleus localization (GO:0040023) | 2.86835862 |
| 76 | mannose metabolic process (GO:0006013) | 2.86765894 |
| 77 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.86277474 |
| 78 | auditory behavior (GO:0031223) | 2.85751530 |
| 79 | vesicle transport along microtubule (GO:0047496) | 2.85277716 |
| 80 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.84490673 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.83513129 |
| 82 | stress granule assembly (GO:0034063) | 2.80917582 |
| 83 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.78986134 |
| 84 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.78723018 |
| 85 | regulation of neurotransmitter levels (GO:0001505) | 2.76425590 |
| 86 | prepulse inhibition (GO:0060134) | 2.73925867 |
| 87 | ethanol oxidation (GO:0006069) | 2.72402005 |
| 88 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.71925860 |
| 89 | atrioventricular valve morphogenesis (GO:0003181) | 2.71592723 |
| 90 | lung epithelium development (GO:0060428) | 2.70869268 |
| 91 | corticosteroid receptor signaling pathway (GO:0031958) | 2.70004192 |
| 92 | embryonic process involved in female pregnancy (GO:0060136) | 2.69755262 |
| 93 | synaptic transmission, glutamatergic (GO:0035249) | 2.68169732 |
| 94 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.68030421 |
| 95 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.66235211 |
| 96 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.66022498 |
| 97 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.65594872 |
| 98 | cerebellar Purkinje cell layer development (GO:0021680) | 2.64842491 |
| 99 | dendritic spine organization (GO:0097061) | 2.64036935 |
| 100 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.63125986 |
| 101 | positive regulation of synapse maturation (GO:0090129) | 2.62240494 |
| 102 | response to auditory stimulus (GO:0010996) | 2.62229049 |
| 103 | semaphorin-plexin signaling pathway (GO:0071526) | 2.61415798 |
| 104 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.60957958 |
| 105 | positive regulation of potassium ion transport (GO:0043268) | 2.60896956 |
| 106 | membrane depolarization during action potential (GO:0086010) | 2.60812401 |
| 107 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.59787210 |
| 108 | activation of Rac GTPase activity (GO:0032863) | 2.59769358 |
| 109 | innervation (GO:0060384) | 2.59502663 |
| 110 | creatine metabolic process (GO:0006600) | 2.59135226 |
| 111 | regulation of synaptic plasticity (GO:0048167) | 2.58895665 |
| 112 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.58753442 |
| 113 | amino acid import (GO:0043090) | 2.58075526 |
| 114 | plasma membrane repair (GO:0001778) | 2.57909490 |
| 115 | cell-cell junction maintenance (GO:0045217) | 2.57083681 |
| 116 | ethanol metabolic process (GO:0006067) | 2.56746314 |
| 117 | regulation of early endosome to late endosome transport (GO:2000641) | 2.55820813 |
| 118 | protein retention in ER lumen (GO:0006621) | 2.54171774 |
| 119 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.53305331 |
| 120 | cerebellar granule cell differentiation (GO:0021707) | 2.53145591 |
| 121 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.53089845 |
| 122 | chemosensory behavior (GO:0007635) | 2.52946540 |
| 123 | positive regulation of sodium ion transport (GO:0010765) | 2.52735808 |
| 124 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.52563404 |
| 125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.51121641 |
| 126 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.50893037 |
| 127 | cardiac conduction (GO:0061337) | 2.50524547 |
| 128 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.49932403 |
| 129 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.49932403 |
| 130 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.49683919 |
| 131 | synaptic vesicle endocytosis (GO:0048488) | 2.49657574 |
| 132 | neuron-neuron synaptic transmission (GO:0007270) | 2.49610864 |
| 133 | regulation of neurotransmitter secretion (GO:0046928) | 2.49130849 |
| 134 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.48849619 |
| 135 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.48782868 |
| 136 | mating behavior (GO:0007617) | 2.48668320 |
| 137 | glutamate receptor signaling pathway (GO:0007215) | 2.48354589 |
| 138 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.48202101 |
| 139 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.47581287 |
| 140 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.47353850 |
| 141 | negative regulation of histone methylation (GO:0031061) | 2.46929078 |
| 142 | regulation of postsynaptic membrane potential (GO:0060078) | 2.46768947 |
| 143 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46502979 |
| 144 | actin filament depolymerization (GO:0030042) | 2.46146977 |
| 145 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.46027222 |
| 146 | histone H3-K9 demethylation (GO:0033169) | 2.41502703 |
| 147 | negative regulation of myotube differentiation (GO:0010832) | 2.40116106 |
| 148 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.38578707 |
| 149 | maternal placenta development (GO:0001893) | 2.37199880 |
| 150 | basement membrane organization (GO:0071711) | 2.36429970 |
| 151 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.34495918 |
| 152 | L-amino acid import (GO:0043092) | 2.34063017 |
| 153 | negative regulation of cell size (GO:0045792) | 2.33894268 |
| 154 | regulation of interleukin-13 production (GO:0032656) | 2.31485015 |
| 155 | cellular response to reactive nitrogen species (GO:1902170) | 2.30961543 |
| 156 | apoptotic process involved in morphogenesis (GO:0060561) | 2.30535802 |
| 157 | cell junction maintenance (GO:0034331) | 2.29975134 |
| 158 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.29670193 |
| 159 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.28846695 |
| 160 | regulation of cholesterol metabolic process (GO:0090181) | 2.26975578 |
| 161 | regulation of extracellular matrix organization (GO:1903053) | 2.25910366 |
| 162 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.25847644 |
| 163 | regulation of histone H3-K4 methylation (GO:0051569) | 2.24705484 |
| 164 | motile cilium assembly (GO:0044458) | 2.24414515 |
| 165 | response to parathyroid hormone (GO:0071107) | 2.24002813 |
| 166 | cellular response to prostaglandin stimulus (GO:0071379) | 2.23616740 |
| 167 | cellular response to nitric oxide (GO:0071732) | 2.22214420 |
| 168 | sodium ion homeostasis (GO:0055078) | 2.21808913 |
| 169 | urea cycle (GO:0000050) | 2.21539796 |
| 170 | response to vitamin A (GO:0033189) | 2.20760360 |
| 171 | urea metabolic process (GO:0019627) | 2.20213704 |
| 172 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.20130733 |
| 173 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.20113507 |
| 174 | response to mercury ion (GO:0046689) | 2.19838346 |
| 175 | proline biosynthetic process (GO:0006561) | 2.19776538 |
| 176 | regulation of bile acid biosynthetic process (GO:0070857) | 2.19576133 |
| 177 | histone H3-K4 methylation (GO:0051568) | 2.19409024 |
| 178 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.19201603 |
| 179 | positive regulation of extracellular matrix organization (GO:1903055) | 2.18454562 |
| 180 | response to epidermal growth factor (GO:0070849) | 2.17610387 |
| 181 | phosphate ion transmembrane transport (GO:0035435) | 2.17285840 |
| 182 | G1 DNA damage checkpoint (GO:0044783) | 2.17197379 |
| 183 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.17003810 |
| 184 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.16908479 |
| 185 | dopamine receptor signaling pathway (GO:0007212) | 2.16730064 |
| 186 | regulation of mitotic spindle organization (GO:0060236) | 2.16600527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.02383947 |
| 2 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82239612 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.60910803 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.60796600 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.39355918 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39180830 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.29531468 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.28417562 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22311849 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22311849 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20780553 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.20566839 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20120518 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17284707 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.15484090 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.13827263 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10637325 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.08579798 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05949263 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94845787 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.93352927 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91108741 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88507439 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86685661 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.84954472 |
| 26 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.84908719 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84464337 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.84270856 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.81400906 |
| 30 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.80211597 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79344345 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76056495 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75401247 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75179487 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.73958073 |
| 36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.71114732 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70306796 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.69886176 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69342825 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.67276772 |
| 41 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.65805863 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62258404 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60059977 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59891368 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59443125 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.55772142 |
| 47 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.55402563 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.54940265 |
| 49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53753325 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50024360 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49566741 |
| 52 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.48613115 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47836834 |
| 54 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.47106993 |
| 55 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.45060952 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44535183 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44490484 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44426570 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44381445 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44102760 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43768492 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43154015 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42688104 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42633437 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41791471 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41394845 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40980592 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40108942 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35237756 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.35052267 |
| 71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33772393 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.33057979 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32076389 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32014128 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31678915 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31471755 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30697928 |
| 78 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30148918 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29443346 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27250543 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26979213 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26840442 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26702900 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25061159 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24831342 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23639472 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23622589 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21892721 |
| 89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21297547 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20520268 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20124742 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20055079 |
| 93 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19242067 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19102458 |
| 95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18536633 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17252879 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17051506 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16962838 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16837444 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16010049 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15951411 |
| 102 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15802225 |
| 103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15158002 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14950001 |
| 105 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13500301 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12486462 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11249538 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11069480 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11027122 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10813667 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10153409 |
| 112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09192721 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08583113 |
| 114 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07667651 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07505346 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06953812 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05774310 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05292808 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04695876 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04473903 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04461717 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04205709 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02401884 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02197640 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01989749 |
| 126 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00545690 |
| 127 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00351818 |
| 128 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99215519 |
| 129 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.97675614 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96618575 |
| 131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95923541 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95418892 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95240320 |
| 134 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95118706 |
| 135 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94994843 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93742650 |
| 137 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92979875 |
| 138 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92884207 |
| 139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92667299 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92521152 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92481864 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92080396 |
| 143 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91947016 |
| 144 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91818038 |
| 145 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91800096 |
| 146 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91383890 |
| 147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91017218 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90977599 |
| 149 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90889012 |
| 150 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90889012 |
| 151 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.90691781 |
| 152 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90602342 |
| 153 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89818577 |
| 154 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89692796 |
| 155 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89422669 |
| 156 | MAF_26560356_Chip-Seq_TH1_Human | 0.89223038 |
| 157 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89095716 |
| 158 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88899631 |
| 159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88092687 |
| 160 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87499552 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87136475 |
| 162 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87031982 |
| 163 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86314005 |
| 164 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86149959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.06263152 |
| 2 | MP0005409_darkened_coat_color | 3.46826742 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.41823137 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 3.10552099 |
| 5 | MP0004270_analgesia | 3.09450609 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.86854251 |
| 7 | MP0005670_abnormal_white_adipose | 2.80235606 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.77958310 |
| 9 | MP0002822_catalepsy | 2.71127239 |
| 10 | MP0004043_abnormal_pH_regulation | 2.56130088 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.55876607 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.54854216 |
| 13 | MP0009745_abnormal_behavioral_response | 2.44214926 |
| 14 | MP0008961_abnormal_basal_metabolism | 2.36049401 |
| 15 | MP0000751_myopathy | 2.26112478 |
| 16 | MP0002064_seizures | 2.21287786 |
| 17 | MP0002249_abnormal_larynx_morphology | 2.15304824 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.15174610 |
| 19 | MP0009046_muscle_twitch | 2.14848604 |
| 20 | MP0000678_abnormal_parathyroid_gland | 2.04951928 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.04203398 |
| 22 | MP0004215_abnormal_myocardial_fiber | 2.03567822 |
| 23 | MP0002009_preneoplasia | 2.00946151 |
| 24 | MP0001486_abnormal_startle_reflex | 1.96084220 |
| 25 | MP0003880_abnormal_central_pattern | 1.95109866 |
| 26 | MP0004885_abnormal_endolymph | 1.94079944 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.93505628 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.90618151 |
| 29 | MP0008569_lethality_at_weaning | 1.86743069 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.85176250 |
| 31 | MP0004130_abnormal_muscle_cell | 1.84097804 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.79206248 |
| 33 | MP0004782_abnormal_surfactant_physiolog | 1.72722756 |
| 34 | MP0003879_abnormal_hair_cell | 1.69807052 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.69336182 |
| 36 | MP0003283_abnormal_digestive_organ | 1.68873784 |
| 37 | MP0002272_abnormal_nervous_system | 1.66650849 |
| 38 | MP0003329_amyloid_beta_deposits | 1.66600457 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.66023560 |
| 40 | MP0004858_abnormal_nervous_system | 1.61030757 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.58783072 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.58297647 |
| 43 | MP0003646_muscle_fatigue | 1.55926660 |
| 44 | MP0009115_abnormal_fat_cell | 1.53972802 |
| 45 | MP0000566_synostosis | 1.53074442 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.52650135 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.52577007 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.52471497 |
| 49 | MP0004233_abnormal_muscle_weight | 1.52298141 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.51658983 |
| 51 | MP0005365_abnormal_bile_salt | 1.50896078 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.50065803 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.45895220 |
| 54 | MP0003868_abnormal_feces_composition | 1.44020200 |
| 55 | MP0002971_abnormal_brown_adipose | 1.43950354 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.42350859 |
| 57 | MP0009672_abnormal_birth_weight | 1.41617851 |
| 58 | MP0004811_abnormal_neuron_physiology | 1.41441902 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.41274405 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.35451620 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.35450752 |
| 62 | MP0002970_abnormal_white_adipose | 1.35215739 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.31256492 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.30076244 |
| 65 | MP0004924_abnormal_behavior | 1.30076244 |
| 66 | MP0003787_abnormal_imprinting | 1.30045484 |
| 67 | MP0001849_ear_inflammation | 1.28828561 |
| 68 | MP0005451_abnormal_body_composition | 1.25329491 |
| 69 | MP0004484_altered_response_of | 1.25002768 |
| 70 | MP0005187_abnormal_penis_morphology | 1.24759951 |
| 71 | MP0001730_embryonic_growth_arrest | 1.24667937 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.23445621 |
| 73 | MP0000003_abnormal_adipose_tissue | 1.23300633 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.22905150 |
| 75 | MP0002067_abnormal_sensory_capabilities | 1.22256562 |
| 76 | MP0003633_abnormal_nervous_system | 1.21134959 |
| 77 | MP0001970_abnormal_pain_threshold | 1.20577553 |
| 78 | MP0000747_muscle_weakness | 1.17985165 |
| 79 | MP0005535_abnormal_body_temperature | 1.17779709 |
| 80 | MP0004085_abnormal_heartbeat | 1.16949335 |
| 81 | MP0004087_abnormal_muscle_fiber | 1.15126830 |
| 82 | MP0002796_impaired_skin_barrier | 1.15077909 |
| 83 | MP0001666_abnormal_nutrient_absorption | 1.14907835 |
| 84 | MP0003137_abnormal_impulse_conducting | 1.14634558 |
| 85 | MP0000955_abnormal_spinal_cord | 1.14371844 |
| 86 | MP0003091_abnormal_cell_migration | 1.13573568 |
| 87 | MP0003566_abnormal_cell_adhesion | 1.13158733 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.13145108 |
| 89 | MP0002184_abnormal_innervation | 1.11967994 |
| 90 | MP0005623_abnormal_meninges_morphology | 1.11491953 |
| 91 | MP0005620_abnormal_muscle_contractility | 1.09991381 |
| 92 | MP0005330_cardiomyopathy | 1.09481830 |
| 93 | MP0008775_abnormal_heart_ventricle | 1.09279520 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 1.08166927 |
| 95 | MP0005503_abnormal_tendon_morphology | 1.06046100 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 1.02130913 |
| 97 | MP0001346_abnormal_lacrimal_gland | 1.01024434 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 1.00257398 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.99317236 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.97950195 |
| 101 | MP0003300_gastrointestinal_ulcer | 0.97526241 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.97302333 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.96861426 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.96840746 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.95101859 |
| 106 | MP0009840_abnormal_foam_cell | 0.93392493 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.92692372 |
| 108 | MP0002882_abnormal_neuron_morphology | 0.91774342 |
| 109 | MP0000778_abnormal_nervous_system | 0.89967293 |
| 110 | MP0003690_abnormal_glial_cell | 0.89590161 |
| 111 | MP0002089_abnormal_postnatal_growth/wei | 0.89052809 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.87133094 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.87115061 |
| 114 | MP0002269_muscular_atrophy | 0.85639665 |
| 115 | MP0003631_nervous_system_phenotype | 0.85448456 |
| 116 | MP0003115_abnormal_respiratory_system | 0.83171897 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.83114755 |
| 118 | MP0003122_maternal_imprinting | 0.82938355 |
| 119 | MP0001177_atelectasis | 0.82291369 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.81919401 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.80839901 |
| 122 | MP0003045_fibrosis | 0.80729490 |
| 123 | MP0002152_abnormal_brain_morphology | 0.80592998 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.80481950 |
| 125 | MP0002108_abnormal_muscle_morphology | 0.80480036 |
| 126 | MP0005360_urolithiasis | 0.80191953 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.80145183 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.79990598 |
| 129 | MP0008872_abnormal_physiological_respon | 0.79028507 |
| 130 | MP0003183_abnormal_peptide_metabolism | 0.78393094 |
| 131 | MP0003075_altered_response_to | 0.77030941 |
| 132 | MP0000733_abnormal_muscle_development | 0.76995895 |
| 133 | MP0005621_abnormal_cell_physiology | 0.76519613 |
| 134 | MP0005645_abnormal_hypothalamus_physiol | 0.76211748 |
| 135 | MP0010630_abnormal_cardiac_muscle | 0.74424518 |
| 136 | MP0002736_abnormal_nociception_after | 0.73616220 |
| 137 | MP0003959_abnormal_lean_body | 0.73511972 |
| 138 | MP0006138_congestive_heart_failure | 0.73393664 |
| 139 | MP0001270_distended_abdomen | 0.73331542 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.72697786 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.72575085 |
| 142 | MP0002090_abnormal_vision | 0.72118451 |
| 143 | MP0001731_abnormal_postnatal_growth | 0.71459554 |
| 144 | MP0000604_amyloidosis | 0.69975996 |
| 145 | MP0005369_muscle_phenotype | 0.69111007 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.69083566 |
| 147 | MP0003111_abnormal_nucleus_morphology | 0.69074032 |
| 148 | MP0008874_decreased_physiological_sensi | 0.68890940 |
| 149 | MP0003984_embryonic_growth_retardation | 0.68882972 |
| 150 | MP0005334_abnormal_fat_pad | 0.67340343 |
| 151 | MP0000759_abnormal_skeletal_muscle | 0.66152720 |
| 152 | MP0000609_abnormal_liver_physiology | 0.65582174 |
| 153 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65133777 |
| 154 | MP0010352_gastrointestinal_tract_polyps | 0.65022325 |
| 155 | MP0004381_abnormal_hair_follicle | 0.64625484 |
| 156 | MP0000266_abnormal_heart_morphology | 0.64313645 |
| 157 | MP0005501_abnormal_skin_physiology | 0.63226173 |
| 158 | MP0008057_abnormal_DNA_replication | 0.63103815 |
| 159 | MP0001672_abnormal_embryogenesis/_devel | 0.62629454 |
| 160 | MP0005380_embryogenesis_phenotype | 0.62629454 |
| 161 | MP0002088_abnormal_embryonic_growth/wei | 0.61929840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.79880439 |
| 2 | Visual hallucinations (HP:0002367) | 4.43254456 |
| 3 | Focal motor seizures (HP:0011153) | 4.07190987 |
| 4 | Ventricular fibrillation (HP:0001663) | 3.87994314 |
| 5 | Action tremor (HP:0002345) | 3.72082634 |
| 6 | Papilledema (HP:0001085) | 3.68952616 |
| 7 | Focal seizures (HP:0007359) | 3.59604046 |
| 8 | Bundle branch block (HP:0011710) | 3.55288650 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.51764756 |
| 10 | Depression (HP:0000716) | 3.01768913 |
| 11 | Impaired social interactions (HP:0000735) | 2.96405261 |
| 12 | Abnormal social behavior (HP:0012433) | 2.96405261 |
| 13 | Postural instability (HP:0002172) | 2.93628966 |
| 14 | Dysmetric saccades (HP:0000641) | 2.91618625 |
| 15 | Poor eye contact (HP:0000817) | 2.90697904 |
| 16 | Genetic anticipation (HP:0003743) | 2.89017032 |
| 17 | Bronchomalacia (HP:0002780) | 2.86998918 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 2.86994801 |
| 19 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.84715133 |
| 20 | Dysdiadochokinesis (HP:0002075) | 2.83319264 |
| 21 | Exercise-induced myalgia (HP:0003738) | 2.82227174 |
| 22 | Ankle clonus (HP:0011448) | 2.78825993 |
| 23 | Macroorchidism (HP:0000053) | 2.77600091 |
| 24 | Hyperactive renin-angiotensin system (HP:0000841) | 2.72510885 |
| 25 | Urethral obstruction (HP:0000796) | 2.71889098 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 2.70089214 |
| 27 | Abnormality of the fingertips (HP:0001211) | 2.69815920 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69070920 |
| 29 | Sudden death (HP:0001699) | 2.67897490 |
| 30 | Abnormality of the lower motor neuron (HP:0002366) | 2.65826797 |
| 31 | Absence seizures (HP:0002121) | 2.63119950 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 2.62749321 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.61062284 |
| 34 | Anxiety (HP:0000739) | 2.55776872 |
| 35 | Prolonged QT interval (HP:0001657) | 2.55075277 |
| 36 | Gout (HP:0001997) | 2.54329874 |
| 37 | Hemiplegia (HP:0002301) | 2.53632922 |
| 38 | Hemorrhage of the eye (HP:0011885) | 2.52088133 |
| 39 | Atelectasis (HP:0100750) | 2.48709641 |
| 40 | Epileptic encephalopathy (HP:0200134) | 2.46419487 |
| 41 | Urinary urgency (HP:0000012) | 2.46149426 |
| 42 | Mutism (HP:0002300) | 2.46097220 |
| 43 | Torticollis (HP:0000473) | 2.42880092 |
| 44 | Broad-based gait (HP:0002136) | 2.42455268 |
| 45 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42165172 |
| 46 | Truncus arteriosus (HP:0001660) | 2.40012105 |
| 47 | Insomnia (HP:0100785) | 2.38319686 |
| 48 | Flat acetabular roof (HP:0003180) | 2.37791339 |
| 49 | Broad face (HP:0000283) | 2.34300388 |
| 50 | Syncope (HP:0001279) | 2.33994922 |
| 51 | Heart block (HP:0012722) | 2.32516417 |
| 52 | Abnormal EKG (HP:0003115) | 2.32150205 |
| 53 | Ketoacidosis (HP:0001993) | 2.30544062 |
| 54 | Intention tremor (HP:0002080) | 2.27037165 |
| 55 | Atrioventricular block (HP:0001678) | 2.24938903 |
| 56 | Agitation (HP:0000713) | 2.24312625 |
| 57 | Bowel incontinence (HP:0002607) | 2.24255966 |
| 58 | Impaired smooth pursuit (HP:0007772) | 2.23033412 |
| 59 | Dysmetria (HP:0001310) | 2.20968086 |
| 60 | Febrile seizures (HP:0002373) | 2.20696262 |
| 61 | Atonic seizures (HP:0010819) | 2.20037775 |
| 62 | Ventricular arrhythmia (HP:0004308) | 2.19992253 |
| 63 | Resting tremor (HP:0002322) | 2.19924237 |
| 64 | Hypercortisolism (HP:0001578) | 2.19569522 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.18607347 |
| 66 | Enlarged penis (HP:0000040) | 2.17541307 |
| 67 | Sparse lateral eyebrow (HP:0005338) | 2.17064241 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.16918670 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15079774 |
| 70 | Atrial fibrillation (HP:0005110) | 2.14289161 |
| 71 | Ankyloglossia (HP:0010296) | 2.13949715 |
| 72 | Broad palm (HP:0001169) | 2.13387837 |
| 73 | Dialeptic seizures (HP:0011146) | 2.12216427 |
| 74 | Elfin facies (HP:0004428) | 2.10933349 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10252287 |
| 76 | Asymmetry of the thorax (HP:0001555) | 2.10026160 |
| 77 | Focal dystonia (HP:0004373) | 2.10009888 |
| 78 | Increased circulating renin level (HP:0000848) | 2.09412666 |
| 79 | Pseudobulbar signs (HP:0002200) | 2.08943407 |
| 80 | Primary atrial arrhythmia (HP:0001692) | 2.08694075 |
| 81 | Exercise-induced muscle cramps (HP:0003710) | 2.08660670 |
| 82 | Myoglobinuria (HP:0002913) | 2.05720959 |
| 83 | Pointed chin (HP:0000307) | 2.04801583 |
| 84 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.04602190 |
| 85 | Abnormal atrioventricular conduction (HP:0005150) | 2.04588893 |
| 86 | Difficulty running (HP:0009046) | 2.03801966 |
| 87 | Hyperacusis (HP:0010780) | 2.03439176 |
| 88 | Megalencephaly (HP:0001355) | 2.02179670 |
| 89 | Obstructive sleep apnea (HP:0002870) | 2.01745524 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 2.01242965 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.00419484 |
| 92 | Status epilepticus (HP:0002133) | 1.98658745 |
| 93 | Truncal ataxia (HP:0002078) | 1.98577592 |
| 94 | Bradykinesia (HP:0002067) | 1.98130144 |
| 95 | Adrenal overactivity (HP:0002717) | 1.98061280 |
| 96 | Right ventricular cardiomyopathy (HP:0011663) | 1.97921615 |
| 97 | Seborrheic dermatitis (HP:0001051) | 1.97563568 |
| 98 | J-shaped sella turcica (HP:0002680) | 1.96262701 |
| 99 | Abnormal large intestine physiology (HP:0012700) | 1.95800331 |
| 100 | Abnormality of the thoracic spine (HP:0100711) | 1.91313760 |
| 101 | Craniofacial dystonia (HP:0012179) | 1.90548904 |
| 102 | Abnormality of chloride homeostasis (HP:0011422) | 1.90403344 |
| 103 | Insidious onset (HP:0003587) | 1.89960395 |
| 104 | Termporal pattern (HP:0011008) | 1.89960395 |
| 105 | Hypoglycemic coma (HP:0001325) | 1.89704656 |
| 106 | Drooling (HP:0002307) | 1.89437153 |
| 107 | Excessive salivation (HP:0003781) | 1.89437153 |
| 108 | Supraventricular tachycardia (HP:0004755) | 1.88183650 |
| 109 | Tetraplegia (HP:0002445) | 1.87184778 |
| 110 | Increased nuchal translucency (HP:0010880) | 1.85028417 |
| 111 | Annular pancreas (HP:0001734) | 1.84345867 |
| 112 | Abnormality of renin-angiotensin system (HP:0000847) | 1.84340991 |
| 113 | Septate vagina (HP:0001153) | 1.84244974 |
| 114 | Hammertoe (HP:0001765) | 1.84037738 |
| 115 | Neoplasm of the heart (HP:0100544) | 1.84021473 |
| 116 | Lip pit (HP:0100267) | 1.83991661 |
| 117 | Stereotypic behavior (HP:0000733) | 1.83957253 |
| 118 | Lymphangioma (HP:0100764) | 1.83341591 |
| 119 | Postural tremor (HP:0002174) | 1.83323301 |
| 120 | Supraventricular arrhythmia (HP:0005115) | 1.83286737 |
| 121 | Long eyelashes (HP:0000527) | 1.82114261 |
| 122 | Hypercholesterolemia (HP:0003124) | 1.81570355 |
| 123 | Abnormality of binocular vision (HP:0011514) | 1.81546402 |
| 124 | Diplopia (HP:0000651) | 1.81546402 |
| 125 | Protrusio acetabuli (HP:0003179) | 1.80324577 |
| 126 | Renovascular hypertension (HP:0100817) | 1.80005620 |
| 127 | Hyperkalemia (HP:0002153) | 1.79746433 |
| 128 | Overriding aorta (HP:0002623) | 1.78567011 |
| 129 | Shallow orbits (HP:0000586) | 1.78566345 |
| 130 | Distal lower limb muscle weakness (HP:0009053) | 1.78343707 |
| 131 | Cerebral aneurysm (HP:0004944) | 1.77252405 |
| 132 | Growth hormone excess (HP:0000845) | 1.77052300 |
| 133 | Pheochromocytoma (HP:0002666) | 1.76961096 |
| 134 | Neurofibrillary tangles (HP:0002185) | 1.76926124 |
| 135 | Hyperaldosteronism (HP:0000859) | 1.76553037 |
| 136 | Vertebral arch anomaly (HP:0008438) | 1.76382858 |
| 137 | Lower limb asymmetry (HP:0100559) | 1.76235800 |
| 138 | Spastic gait (HP:0002064) | 1.75210952 |
| 139 | Impaired vibratory sensation (HP:0002495) | 1.74917935 |
| 140 | Ketosis (HP:0001946) | 1.74561223 |
| 141 | Papillary thyroid carcinoma (HP:0002895) | 1.73379088 |
| 142 | Clonus (HP:0002169) | 1.72394763 |
| 143 | Hyperphosphatemia (HP:0002905) | 1.71747845 |
| 144 | Aneurysm (HP:0002617) | 1.71569166 |
| 145 | Hyperparathyroidism (HP:0000843) | 1.70651703 |
| 146 | EEG with generalized epileptiform discharges (HP:0011198) | 1.70566481 |
| 147 | Hypsarrhythmia (HP:0002521) | 1.69255701 |
| 148 | Upper limb amyotrophy (HP:0009129) | 1.68869246 |
| 149 | Distal upper limb amyotrophy (HP:0007149) | 1.68869246 |
| 150 | Complement deficiency (HP:0004431) | 1.68262902 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.67691671 |
| 152 | Cerebral inclusion bodies (HP:0100314) | 1.67668590 |
| 153 | Hypokalemic alkalosis (HP:0001949) | 1.67232513 |
| 154 | Hyperthyroidism (HP:0000836) | 1.66731070 |
| 155 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65245750 |
| 156 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65212751 |
| 157 | Foot dorsiflexor weakness (HP:0009027) | 1.65170301 |
| 158 | Abnormality of the salivary glands (HP:0010286) | 1.63164366 |
| 159 | Metaphyseal cupping (HP:0003021) | 1.62177162 |
| 160 | Recurrent otitis media (HP:0000403) | 1.61784800 |
| 161 | Advanced eruption of teeth (HP:0006288) | 1.60677618 |
| 162 | Abnormality of the aortic arch (HP:0012303) | 1.58746035 |
| 163 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.58577460 |
| 164 | Male infertility (HP:0003251) | 1.57790168 |
| 165 | Onion bulb formation (HP:0003383) | 1.56535564 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.54821354 |
| 167 | Abnormality of the foot musculature (HP:0001436) | 1.54562411 |
| 168 | Reticulocytosis (HP:0001923) | 1.53991301 |
| 169 | Precocious puberty (HP:0000826) | 1.53444869 |
| 170 | Hand muscle atrophy (HP:0009130) | 1.53074920 |
| 171 | Renal salt wasting (HP:0000127) | 1.53000693 |
| 172 | Bell-shaped thorax (HP:0001591) | 1.52536154 |
| 173 | Flat cornea (HP:0007720) | 1.52509481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.43742531 |
| 2 | NTRK3 | 3.24925729 |
| 3 | PRKD3 | 3.11392448 |
| 4 | FGFR4 | 2.89514485 |
| 5 | EEF2K | 2.69561975 |
| 6 | MARK1 | 2.63931700 |
| 7 | EPHA4 | 2.62276910 |
| 8 | PRPF4B | 2.61422667 |
| 9 | MAP3K4 | 2.34589454 |
| 10 | SMG1 | 2.33460123 |
| 11 | PAK6 | 2.29803428 |
| 12 | NEK1 | 2.24402163 |
| 13 | KSR2 | 2.19740480 |
| 14 | TRIB3 | 2.18437273 |
| 15 | DAPK2 | 2.17344511 |
| 16 | AKT3 | 2.17072901 |
| 17 | CAMKK1 | 2.16780462 |
| 18 | RIPK1 | 2.15573989 |
| 19 | MINK1 | 2.15031145 |
| 20 | STK38 | 2.06715341 |
| 21 | LMTK2 | 2.03908988 |
| 22 | TAOK1 | 1.98828673 |
| 23 | ERN1 | 1.98245827 |
| 24 | PHKG2 | 1.71707683 |
| 25 | PHKG1 | 1.71707683 |
| 26 | MAP2K4 | 1.66005813 |
| 27 | PKN2 | 1.64432774 |
| 28 | NTRK2 | 1.63815396 |
| 29 | EPHA2 | 1.54834021 |
| 30 | CAMK1G | 1.52476426 |
| 31 | MAP3K2 | 1.51414605 |
| 32 | NTRK1 | 1.50226282 |
| 33 | MAPKAPK3 | 1.44467201 |
| 34 | MAP3K10 | 1.43458031 |
| 35 | MST1R | 1.40459357 |
| 36 | ALK | 1.38027516 |
| 37 | LATS2 | 1.37041614 |
| 38 | RIPK4 | 1.36344147 |
| 39 | PAK3 | 1.33892389 |
| 40 | MAPK15 | 1.32993007 |
| 41 | DMPK | 1.30664454 |
| 42 | WNK4 | 1.25362683 |
| 43 | TYRO3 | 1.25076403 |
| 44 | RET | 1.22560612 |
| 45 | PRKCH | 1.21037567 |
| 46 | SCYL2 | 1.19547930 |
| 47 | CDK5 | 1.19277677 |
| 48 | MAP2K7 | 1.17919660 |
| 49 | KSR1 | 1.16588948 |
| 50 | MAP3K7 | 1.11069108 |
| 51 | WNK1 | 1.10772875 |
| 52 | EPHB1 | 1.09722280 |
| 53 | STK11 | 1.09608771 |
| 54 | WNK3 | 1.09501316 |
| 55 | CAMK1 | 1.09363712 |
| 56 | CAMK1D | 1.08158028 |
| 57 | PDK3 | 1.05579156 |
| 58 | PDK4 | 1.05579156 |
| 59 | SIK2 | 1.01840978 |
| 60 | PINK1 | 1.00376538 |
| 61 | MAPK11 | 1.00233144 |
| 62 | CDC42BPA | 0.97652179 |
| 63 | PDGFRA | 0.95874685 |
| 64 | SGK3 | 0.91568496 |
| 65 | CAMKK2 | 0.90292353 |
| 66 | HIPK2 | 0.83890038 |
| 67 | BMX | 0.82737049 |
| 68 | NEK6 | 0.82227100 |
| 69 | MAPK12 | 0.81513645 |
| 70 | PDK1 | 0.81277924 |
| 71 | PRKCG | 0.77021785 |
| 72 | TNK2 | 0.76928237 |
| 73 | PDPK1 | 0.76495063 |
| 74 | MARK2 | 0.75390099 |
| 75 | MAP3K13 | 0.74364393 |
| 76 | FRK | 0.73143525 |
| 77 | UHMK1 | 0.72298916 |
| 78 | SGK1 | 0.72214072 |
| 79 | MAP3K1 | 0.71627358 |
| 80 | TRPM7 | 0.71458294 |
| 81 | MAP3K6 | 0.70741521 |
| 82 | CDK4 | 0.68303351 |
| 83 | SGK223 | 0.68237520 |
| 84 | SGK494 | 0.68237520 |
| 85 | CDK12 | 0.66653095 |
| 86 | CDK9 | 0.65639982 |
| 87 | CAMK4 | 0.64733822 |
| 88 | DAPK1 | 0.63580716 |
| 89 | RPS6KA3 | 0.63485221 |
| 90 | PDGFRB | 0.63240507 |
| 91 | TESK1 | 0.62954748 |
| 92 | PRKD2 | 0.62799052 |
| 93 | SIK3 | 0.62338786 |
| 94 | SGK2 | 0.62096285 |
| 95 | MET | 0.61943597 |
| 96 | INSRR | 0.61898880 |
| 97 | RPS6KB2 | 0.60457014 |
| 98 | FES | 0.59254023 |
| 99 | MAP2K2 | 0.59231888 |
| 100 | PRKAA1 | 0.59198109 |
| 101 | BRSK1 | 0.58013917 |
| 102 | NME1 | 0.57924163 |
| 103 | MAPK10 | 0.57672266 |
| 104 | MAP3K14 | 0.55539321 |
| 105 | DYRK1A | 0.53130376 |
| 106 | CSNK1G2 | 0.52504698 |
| 107 | FER | 0.52452817 |
| 108 | PTK6 | 0.52236876 |
| 109 | LATS1 | 0.51639532 |
| 110 | ICK | 0.50973294 |
| 111 | CAMK2A | 0.49091847 |
| 112 | JAK1 | 0.48797178 |
| 113 | PLK2 | 0.48788622 |
| 114 | PRKCZ | 0.48249822 |
| 115 | GSK3B | 0.48242610 |
| 116 | PRKAA2 | 0.47642488 |
| 117 | MELK | 0.47497433 |
| 118 | RPS6KA2 | 0.47374092 |
| 119 | PTK2 | 0.47338667 |
| 120 | CDK7 | 0.47312184 |
| 121 | PRKD1 | 0.47023925 |
| 122 | CDK6 | 0.46953679 |
| 123 | FGFR2 | 0.46733609 |
| 124 | CDK14 | 0.46239379 |
| 125 | CDK15 | 0.46066039 |
| 126 | DDR2 | 0.45560083 |
| 127 | OXSR1 | 0.45428611 |
| 128 | ITK | 0.45078513 |
| 129 | MAPK8 | 0.44773489 |
| 130 | MAPK7 | 0.44588618 |
| 131 | RAF1 | 0.43959790 |
| 132 | CDK2 | 0.43021714 |
| 133 | ERBB2 | 0.42316771 |
| 134 | SIK1 | 0.42298362 |
| 135 | CDK18 | 0.42213044 |
| 136 | MAPK3 | 0.41399065 |
| 137 | CHEK1 | 0.40811002 |
| 138 | MAPK14 | 0.40806486 |
| 139 | MAP4K1 | 0.40486851 |
| 140 | FYN | 0.40458441 |
| 141 | GRK5 | 0.40176013 |
| 142 | CDK11A | 0.39936014 |
| 143 | MTOR | 0.39666147 |
| 144 | BRD4 | 0.39274681 |
| 145 | FGFR1 | 0.38000811 |
| 146 | TTN | 0.37783112 |
| 147 | PIK3CA | 0.37538096 |
| 148 | FGFR3 | 0.36059205 |
| 149 | PRKACG | 0.35623213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.78590552 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25529394 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.20439977 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.12632727 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.11087939 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.09278257 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.05422218 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.04627886 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.03509891 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.02687904 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.00897970 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.98281465 |
| 13 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.84466312 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84248975 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81317304 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.79655636 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79184499 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.76172450 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.74904337 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74317666 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.73047062 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.65904560 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.60864646 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.60240420 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56839079 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55086230 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42802902 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40001721 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.39941969 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33199426 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31746083 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29149779 |
| 33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27752906 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27066431 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.25696595 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25580811 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21841321 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20758093 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.19070635 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.17321542 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16381686 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15836612 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15189454 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14522648 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14291656 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.10653701 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10547591 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08624455 |
| 49 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.06459992 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.06061761 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05896634 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.03362847 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03019170 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 1.02892913 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.01604702 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98990289 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98718112 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.96226257 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95718330 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93685532 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.93379270 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92930501 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92380720 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.91117963 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89001279 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85950543 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85321210 |
| 68 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.84615459 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84408037 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.83902469 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83034274 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82899903 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82648669 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82369817 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81919310 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80813680 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79553271 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78990871 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78823395 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.78822239 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78326566 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.77950878 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77873613 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75931852 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75765830 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75579098 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75051586 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74400838 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74121225 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73880938 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73319698 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67808224 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67574827 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64519106 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64013119 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63256437 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.63036788 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62308235 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60459964 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.60400302 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59489874 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58691527 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58082489 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57744444 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57509779 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56761166 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56459167 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56071363 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55421398 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54804800 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.54497063 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54247111 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54074437 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53261684 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53228754 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53054926 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52632736 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50893901 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49078113 |
| 120 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48682818 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48649486 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48441111 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46941136 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46260635 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46074682 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45442233 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45354788 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44114021 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43506389 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.38545132 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35495584 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.35211955 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34962806 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34221339 |

